Zobrazeno 1 - 3
of 3
pro vyhledávání: '"LMF Bertoline"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S387- (2024)
Objectives: The TP53 gene encodes the tumor suppressor protein p53, which is crucial in cancer biology. Mutations in TP53 occur in 10 to 20% of AML cases and are associated with an unfavorable prognosis and high refractoriness to chemotherapy. The co
Externí odkaz:
https://doaj.org/article/401b4a6d5ee9486a8252e6a5458108f9
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S419- (2024)
Objetivo: Na leucemia mieloide aguda (LMA), as mutações no gene TP53 são menos comuns em comparação com outros tipos de câncer (10 - 20%), mas, quando presentes, estão frequentemente associadas a um prognóstico muito ruim. Recentemente, Lee e
Externí odkaz:
https://doaj.org/article/eddd0406b5fe4e68bcf6c2607ec0a35a
Autor:
Bertoline LMF; Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of São Paulo Medical School, São Paulo, Brazil., Lima AN; Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of São Paulo Medical School, São Paulo, Brazil., Krieger JE; Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of São Paulo Medical School, São Paulo, Brazil., Teixeira SK; Laboratory of Genetics and Molecular Cardiology, Heart Institute, University of São Paulo Medical School, São Paulo, Brazil.
Publikováno v:
Frontiers in bioinformatics [Front Bioinform] 2023 Feb 28; Vol. 3, pp. 1120370. Date of Electronic Publication: 2023 Feb 28 (Print Publication: 2023).